BRAF targeted therapy changes the treatment paradigm in melanoma

Therapeutic advances in melanoma seem on the horizon, with the identification of BRAF as a principal therapeutic target. The authors describe the scientific basis for the targeting of BRAF mutations in cancer, the early clinical data with BRAF inhibitors, and how combinatorial therapies may address...

Ausführliche Beschreibung